Tixagevimab/cilgavimabTixagevimab/cilgavimab
Common
Rarity: Common
The most frequent rarity: most Wikipedia articles become Commons.
Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.
At a glance
- Class
- Invention
- Domain
- Science and technology
- Knowledge cost
- 4
- In collections
- Nobody has pulled it yet.
What Wikipedia says
Tixagevimab/cilgavimab, sold under the brand name Evusheld, is a combination of two human monoclonal antibodies, tixagevimab (AZD8895) and cilgavimab (AZD1061) targeted against the surface spike protein of SARS-CoV-2 used to prevent COVID-19.
Excerpt from the Wikipedia article “Tixagevimab/cilgavimab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia
Image: Fvasconcellos (talk · contribs), Public domain, via Wikimedia Commons.
Open free boosters and add Tixagevimab/cilgavimab to your collection.
Play for free




